DOP2012000065A - Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico - Google Patents

Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico

Info

Publication number
DOP2012000065A
DOP2012000065A DO2012000065A DO2012000065A DOP2012000065A DO P2012000065 A DOP2012000065 A DO P2012000065A DO 2012000065 A DO2012000065 A DO 2012000065A DO 2012000065 A DO2012000065 A DO 2012000065A DO P2012000065 A DOP2012000065 A DO P2012000065A
Authority
DO
Dominican Republic
Prior art keywords
glucocorticoid
antimicrobial
combination
antimicotic
composition containing
Prior art date
Application number
DO2012000065A
Other languages
English (en)
Inventor
Hernandez Gustavo Barranco
Salgado Lopez Raul Garcia
Original Assignee
Lab Senosiain S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Senosiain S A De C V filed Critical Lab Senosiain S A De C V
Publication of DOP2012000065A publication Critical patent/DOP2012000065A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Abstract

La presente invención se refìere a una composición farmacéutica tópica que comprende la combinación de un antimicrobiano, un glucocorticoide, un antimicótico y vehículos o excipientes farmacéuticamente aceptables; el proceso de fabricación de la composición y el uso de dicha composición para tratamiento de padecimientos localizados de dermatosis.
DO2012000065A 2009-09-15 2012-03-13 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico DOP2012000065A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2009009884A MX2009009884A (es) 2009-09-15 2009-09-15 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico.

Publications (1)

Publication Number Publication Date
DOP2012000065A true DOP2012000065A (es) 2012-05-31

Family

ID=43759111

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2012000065A DOP2012000065A (es) 2009-09-15 2012-03-13 Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico

Country Status (15)

Country Link
US (1) US8895538B2 (es)
EP (1) EP2478908B1 (es)
AR (1) AR078370A1 (es)
BR (1) BR112012005895B8 (es)
CA (1) CA2774356C (es)
CO (1) CO6511242A2 (es)
CR (1) CR20120114A (es)
DO (1) DOP2012000065A (es)
EC (1) ECSP12011727A (es)
ES (1) ES2716505T3 (es)
GT (1) GT201200074A (es)
HN (1) HN2012000527A (es)
MX (1) MX2009009884A (es)
PE (1) PE20121351A1 (es)
WO (1) WO2011033361A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105687206A (zh) * 2014-11-27 2016-06-22 四川海思科制药有限公司 一种夫西地酸戊酸倍他米松乳膏药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298604B1 (en) * 1980-10-06 1998-12-22 Schering Corp Clotrimazole-betamethasone dipropionate combination
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
RU2470645C2 (ru) * 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
WO2010106465A1 (en) * 2009-03-17 2010-09-23 Sulur Subramaniam Vanangamudi A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
WO2010122475A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, clotrimazole and mometasone, and a process to make it
WO2010122491A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it

Also Published As

Publication number Publication date
AR078370A1 (es) 2011-11-02
WO2011033361A2 (es) 2011-03-24
HN2012000527A (es) 2014-09-22
GT201200074A (es) 2014-03-05
PE20121351A1 (es) 2012-10-27
EP2478908A4 (en) 2013-04-03
MX2009009884A (es) 2011-03-16
CR20120114A (es) 2012-06-08
CO6511242A2 (es) 2012-08-31
EP2478908B1 (en) 2018-12-26
WO2011033361A3 (es) 2011-07-21
ECSP12011727A (es) 2012-04-30
US20120178727A1 (en) 2012-07-12
US8895538B2 (en) 2014-11-25
BR112012005895B8 (pt) 2021-05-25
CA2774356C (en) 2017-05-30
ES2716505T3 (es) 2019-06-12
BR112012005895B1 (pt) 2020-11-24
EP2478908A2 (en) 2012-07-25
CA2774356A1 (en) 2011-03-24
BR112012005895A2 (pt) 2017-06-06

Similar Documents

Publication Publication Date Title
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
UY30986A1 (es) Derivados fluorinados de deferiprona
ECSP12012318A (es) Inhibidores de pirazolil quinazolina cinasa
DOP2010000013A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
PA8740901A1 (es) Compuestos organicos
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY30663A1 (es) Dihidropirazolonas sustituidas y su uso
DOP2010000011A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
CR11684A (es) Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa
CL2007001435A1 (es) Compuestos derivados de fenilalanina; proceso de prepatacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto como inhibidores de integrina para el tratamiento del cancer.
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
CL2011000258A1 (es) Compuestos derivados de fenilamino-isonicotinamida; inhibidores de mek; composicion farmaceutica y uso para el tratamiento de enfermedades hiperproliferativas tales como cancer e inflamacion.
SG194463A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
CO6470899A2 (es) 2,4-diaminopirimidinas para el tratamiento de enfermedades caracterizadas por proliferación celular excesiva o normal
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
UY31143A1 (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas
DOP2012000065A (es) Combinacion y composicion que contiene un antimicrobiano, un glucocorticoide y un antimicotico
CL2008003062A1 (es) Compuestos derivados de pirazoles espiro conjugados, inhibidores de la actividad de ksp kinesina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades proliferativas.
ECSP13012765A (es) Combinación y composición para el tratamiento de obesidad
DOP2013000144A (es) Combinacion y composicion para el tratamiento de obesidad
CL2009001493A1 (es) Compuestos derivados de 3-cianopirrolidin-fenil-oxazolidinonas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de infecciones bacterianas.
CL2013003671A1 (es) Composicion y combinacion farmaceutica que comprende ketorolaco y meloxicam; proceso para preparar la composicion; uso en el tratamiento de la inflamacion y el dolor.
CL2010001230A1 (es) Metodo para inhibir la melanogenesis que comprende administrar un compuesto esteroidal; composicin farmaceutica; formulacion topica, util en el tratamiento de una enfermedad o condicion que involucra melanogenesis.